Implementation of digital health technology in clinical trials: the 6R framework

被引：0
作者：
Cristina Ortega Durán
Matthew Bonam
Elisabeth Björk
Rod Hughes
Serban Ghiorghiu
Cristian Massacesi
Alicyn Campbell
Emmette Hutchison
Menelas N. Pangalos
Susan Galbraith
机构：
[1] AstraZeneca PLC,Digital Health Research and Development
[2] AstraZeneca PLC,Cardiovascular, Renal and Metabolism Biopharmaceuticals R&D
[3] AstraZeneca PLC,Research and Early Development, Respiratory and Immunology
[4] AstraZeneca PLC,Oncology
[5] AstraZeneca PLC,Research and Development
[6] AstraZeneca PLC,Digital Health Oncology Research and Development
[7] Emmette Hutchison LLC,Biophamaceuticals Research and Development
[8] AstraZeneca PLC,Oncology Research and Development
[9] AstraZeneca PLC,undefined
来源：
Nature Medicine | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
AstraZeneca has introduced digital health solutions into clinical trials, demonstrating improved patient experience, accelerated timelines and reduced costs.
引用
收藏
页码：2693 / 2697
页数：4
相关论文
共 17 条
[1]  
Thakur S(2021)undefined Perspect Clin. Res. 12 184-188
[2]  
Lahiry S(2020)undefined BMC Med. 18 1602406-198
[3]  
Naidoo N(2020)undefined npj Digital Med. 3 197-2422
[4]  
Inan OT(2017)undefined Eur. Resp. J. 50 2413-431
[5]  
Johannson KA(2017)undefined JAMA 318 106219-181
[6]  
Basch E(2022)undefined JAMA 327 419-S893
[7]  
Basch E(2021)undefined Contemp. Clin. Trials 100 167-S107
[8]  
Rosa C(2014)undefined Nat. Rev. Drug Discov. 13 ehab724.3061-892
[9]  
Cook D(2018)undefined Nat. Rev. Drug Discov. 17 106175-undefined
[10]  
Morgan P(2021)undefined Eur. Heart J. 42 1692-undefined
12